Deregulation of D-type Cyclins in Uterine Cancers. Cyclin D1/D3 is Differentially Expressed in Cervical Cancer

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3929-3935

  Skomedal, H ^a   Forus, A ^a   Holm, R ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cell cycle regulators; Cervix cancer; Corpus cancer; Cyclin D1; Cyclin D3; FISH; Immunohostochemistry; Proliferation

Indexed keywords

CYCLIN D1; CYCLIN D3;

ARTICLE; CHROMOSOME 6; CONTROLLED STUDY; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

CYCLIN D1; CYCLINS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 0345305250     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Michalides RJ: Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol 52: 555-568, 1999.
2. Akiyama T, Ohuchi T, Sumida S, Matsumoto K and Toyoshima K: Phosphorylation of the retinoblastoma protein by cdk2. Proc Natl Acad Sci USA 89: 7900-7904, 1992.
3. Kato J, Matsushime H, Hiebert SW, Ewen ME, and Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342, 1993.
4. Lucas JJ, Szepesi A, Modiano JF, Domenico J and Gelfand EW: Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes. J Immunol 154: 6275-6284, 1995.
5. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S and Dean DC: Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375: 812-815, 1995.
6. Xiong Y, Menninger J, Beach D and Ward DC: Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 13: 575-584, 1992.
7. Bartkova J, Lukas J, Strauss M and Bartek J: Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17: 1027-1037, 1998.
8. Sherr CJ: D-type cyclins. Trends Biochem Sci 20: 187-190, 1995.
9. Hall M and Peters G: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68: 67-108, 1996.
10. Motokura T and Arnold A: Cyclin D and oncogenesis. Curr Opin Genet Dev 3: 5-10, 1993.
11. Fantl V, Smith R, Brookes S, Dickson C and Peters G: Chromosome 11q13 abnormalities in human breast cancer [see comments]. Cancer Surv 18: 77-94, 1993.
12. Hoyer JD, Hanson CA, Fonseca R, Greipp PR, Dewald GW, and Kurtin PJ: The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. Am J Clin Pathol 113: 831-837, 2000.
13. Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, Miyoshi I, Ohtsuki T, Yawata Y and Namba M: Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7: 1401-1406, 1992.
14. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM and Arnold A: A novel cyclin encoded by a bc11-linked candidate oncogene [see comments]. Nature 350: 512-515, 1991.
15. Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P and Rosen N: A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9: 1925-1929, 1994.
16. Doglioni C, Chiarelli C, Macri E, AP, Meggiolaro E, Dalla, Palma P and Barbareschi M: Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol 185: 159-166, 1998.
17. Barnouin K, Fredersdorf S, Eddaoudi A, Mittnacht S, Pan LX, Du MQ and Lu X: Antiproliferative function of p27kipl is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene 18: 6388-6397, 1999.
18. Russell A, Hendley J and Germain D: Inhibitory effect of p21 in MCF-7 cells is overcome by its coordinated stabilization with D-type cyclins. Oncogene 18: 6454-6459, 1999.
19. Sanchez-Beato M, Camacho FI, JC, Saez AI, Villuendas R, Sanchez-Verde L, Garcia JF and Piris MA: Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. Blood 94: 765-772, 1999.
20. Skomedal H, Kristensen GB, Nesland JM, Borresen-Dale AL, Trope C and Holm R: TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus. J Pathol 187: 556-562, 1999.
21. Lam EW, Glassford J, Banerji L, Thomas NS, Sicinski P and Klaus GG: Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem 275: 3479-3484, 2000.
22. Skomedal H, Kristensen GB, Lie AK and Holm R:. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 73: 223-228, 1999.
23. Dulic V, Drullinger LF, Lees E, Reed SI and Stein GH: Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci USA 90: 11034-11038, 1993.
24. Dong F, Cress WD Jr, Agrawal D and Pledger WJ: The role of cyclin D3-dependent kinase in the phosphorylation of p130 in mouse BALB/c 3T3 fibroblasts. J Biol Chem 273: 6190-6195, 1998.
25. Dong F, Agrawal D, Bagui T and Pledger WJ: Cyclin D3-associated kinase activity is regulated by p27kipl inBALB/c 3T3 cells. Mol Biol Cell 9: 2081-2092, 1998.
26. Wong SC, Chan JK, Lee KC and Hsiao WL: Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J Pathol 194: 35-42, 2001.
27. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, Strauss M and Bartek J: DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 125: 625-638, 1994.
28. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M and Strauss M: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91: 2945-2949, 1994.
29. Cobrinik D, Dowdy SF, Hinds PW, Mittnacht S and Weinberg RA: The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 17: 312-315, 1992.
30. Russell A, Thompson MA, Hendley J, Trute L, Armes J and Germain D: Cyclin: D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 18: 1983-1991, 1999.
31. Saito T, Oda Y, Tanaka K, Matsuda S, Tamiya S, Iwamoto Y and Tsuneyoshi M: Beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours. J Pathol 195: 222-228, 2001.